Koo CY - Search Results

1

SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.

Khongkow M, Olmos Y, Gong C, Gomes AR, Monteiro LJ, Yagüe E, Cavaco TB, Khongkow P, Man EP, Laohasinnarong S, Koo CY, Harada-Shoji N, Tsang JW, Coombes RC, Schwer B, Khoo US, Lam EW. Khongkow M, et al. Among authors: koo cy. Carcinogenesis. 2013 Jul;34(7):1476-86. doi: 10.1093/carcin/bgt098. Epub 2013 Mar 20. Carcinogenesis. 2013. PMID: 23514751

2

FOXM1: From cancer initiation to progression and treatment.

Koo CY, Muir KW, Lam EW. Koo CY, et al. Biochim Biophys Acta. 2012 Jan;1819(1):28-37. doi: 10.1016/j.bbagrm.2011.09.004. Epub 2011 Sep 29. Biochim Biophys Acta. 2012. PMID: 21978825 Review.

3

The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.

de Olano N, Koo CY, Monteiro LJ, Pinto PH, Gomes AR, Aligue R, Lam EW. de Olano N, et al. Among authors: koo cy. Mol Cancer Res. 2012 Sep;10(9):1189-202. doi: 10.1158/1541-7786.MCR-11-0559. Epub 2012 Jul 16. Mol Cancer Res. 2012. PMID: 22802261 Free PMC article.

4

Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.

Ho KK, McGuire VA, Koo CY, Muir KW, de Olano N, Maifoshie E, Kelly DJ, McGovern UB, Monteiro LJ, Gomes AR, Nebreda AR, Campbell DG, Arthur JS, Lam EW. Ho KK, et al. Among authors: koo cy. J Biol Chem. 2012 Jan 6;287(2):1545-55. doi: 10.1074/jbc.M111.284224. Epub 2011 Nov 29. J Biol Chem. 2012. PMID: 22128155 Free PMC article.

5

Forkhead box proteins: tuning forks for transcriptional harmony.

Lam EW, Brosens JJ, Gomes AR, Koo CY. Lam EW, et al. Among authors: koo cy. Nat Rev Cancer. 2013 Jul;13(7):482-95. doi: 10.1038/nrc3539. Nat Rev Cancer. 2013. PMID: 23792361 Review.

6

Targeting TAO Kinases Using a New Inhibitor Compound Delays Mitosis and Induces Mitotic Cell Death in Centrosome Amplified Breast Cancer Cells.

Koo CY, Giacomini C, Reyes-Corral M, Olmos Y, Tavares IA, Marson CM, Linardopoulos S, Tutt AN, Morris JDH. Koo CY, et al. Mol Cancer Ther. 2017 Nov;16(11):2410-2421. doi: 10.1158/1535-7163.MCT-17-0077. Epub 2017 Aug 22. Mol Cancer Ther. 2017. PMID: 28830982

7

The dual function of KSR1: a pseudokinase and beyond.

Zhang H, Koo CY, Stebbing J, Giamas G. Zhang H, et al. Among authors: koo cy. Biochem Soc Trans. 2013 Aug;41(4):1078-82. doi: 10.1042/BST20130042. Biochem Soc Trans. 2013. PMID: 23863182 Review.

8

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.

Giacomini C, Koo CY, Yankova N, Tavares IA, Wray S, Noble W, Hanger DP, Morris JDH. Giacomini C, et al. Among authors: koo cy. Acta Neuropathol Commun. 2018 May 7;6(1):37. doi: 10.1186/s40478-018-0539-8. Acta Neuropathol Commun. 2018. PMID: 29730992 Free PMC article.

9

[No title available]

[No authors listed] [No authors listed] PMID: 34005170

10

Rnd3 interacts with TAO kinases and contributes to mitotic cell rounding and spindle positioning.

Garg R, Koo CY, Infante E, Giacomini C, Ridley AJ, Morris JDH. Garg R, et al. Among authors: koo cy. J Cell Sci. 2020 Mar 16;133(6):jcs235895. doi: 10.1242/jcs.235895. J Cell Sci. 2020. PMID: 32041905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters